WASHINGTON D.C.
PRODUCTS & SERVICES
HOW WE HELP
Responsible for some of the most meaningful and effective work in Federal.
LEARN MORE
strategy
Build tactics that impact market dynamics.
-
Landscape assessments
-
Data acquisition
-
Market research
-
Ideation workshops​
-
Federal value differentiation
-
Training
-
Academic affiliate mapping
-
Gap assessments
-
Federal patient journey mapping
contracting
Establish partnerships beyond FSS - built on shared investment.
-
Non-statutory contracting strategy
-
Pricing strategies
-
Market share and volume agreements
-
Outcomes-based contracting
-
Drug / device trial agreements
-
P&T package preparation
-
Agreement negotiation
-
Utilization management offerings
policy
How Federal healthcare systems operate
-
Interpret directives, protocols, guidance and agency policy ​​
-
Impact utilization ​​
-
Identify key points of influence at the programmatic-level ​​​​
-
Align with national-level program offices​​
-
Partner on improvements in patient care
-
Explore operational efficiencies​​
-
Collect intelligence​​​
-
Develop Federal-specific budget impact
engagement
Gain access to stakeholders with influence.
-
Accelerated sales
-
Access and coverage negotiation
-
Pilots and strategic partnerships
-
Limited engagement
-
Access to HQ, KOLs, national program leadership, medical / pharmacy directors
How we think
-
Traditional high-control IDN access strategies lack the nuance required for effective coverage and adoption in Federal.
​
-
In order to properly deliver on the brand ambition, a segment-specific value proposition should be considered that aligns with current unmet need and communicates differentiation in accordance with cultural and operational expectations.
​​
-
Our strategic imperatives center around each clients own brand goals and leverage cross-function collaboration between commercial leadership, account management, government affairs, sales and payer marketing.
​​
-
We believe in fostering strong, long-term relationships between pharmaceutical manufacturers and the Federal community to ensure beneficiaries have maximum access to personalized medicine and preferred therapies.
​​
-
​​By leveraging our established trust, manufacturers are able to proactively established open communication and mutual understanding with Federal stakeholders.